{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:08:57Z","timestamp":1787688537327,"version":"build-2784847793"},"reference-count":172,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.disamonth.2025.102015","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T12:47:10Z","timestamp":1758026830000},"page":"102015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Danon disease: From genetic origins and molecular defects to therapeutic advances"],"prefix":"10.1016","volume":"71","author":[{"given":"Rishabh","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0001","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.disamonth.2025.102015_bib0002","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.0000075270.13497.2B","article-title":"Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy","volume":"107","author":"Arad","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.disamonth.2025.102015_bib0003","first-page":"944","article-title":"Lysosomal storage diseases","volume":"4\u20134","author":"Aronson","year":"2008","journal-title":"Carbohydr Chem Biol"},{"issue":"8","key":"10.1016\/j.disamonth.2025.102015_bib0004","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00431-005-1678-z","article-title":"Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene","volume":"164","author":"Balmer","year":"2005","journal-title":"Eur J Pediatr"},{"issue":"18","key":"10.1016\/j.disamonth.2025.102015_bib0005","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1128\/MCB.02070-07","article-title":"The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane","volume":"28","author":"Bandyopadhyay","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0006","first-page":"13","article-title":"Metabolic maturation exaggerates abnormal calcium handling in a Lamp2 knockout human pluripotent stem cell-derived cardiomyocyte model of Danon disease","author":"Barndt","year":"2023","journal-title":"Biomolecules"},{"issue":"35","key":"10.1016\/j.disamonth.2025.102015_bib0007","doi-asserted-by":"crossref","first-page":"16755","DOI":"10.1016\/S0021-9258(18)66630-X","article-title":"Biosynthesis, glycosylation, movement through the Golgi system, and transport to lysosomes by an N-linked carbohydrate-independent mechanism of three lysosomal integral membrane proteins","volume":"261","author":"Barriocanal","year":"1986","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102015_bib0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-2005-872844","article-title":"Phenotypic heterogeneity in two unrelated danon patients associated with the same LAMP-2 gene mutation","volume":"36","author":"Bertini","year":"2005","journal-title":"Neuropediatrics"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0009","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/GIM.0b013e31820ad795","article-title":"Natural history of Danon disease","volume":"13","author":"Boucek","year":"2011","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0300-8932(10)70074-9","article-title":"Caracterizaci\u00f3n no invasiva de un caso de enfermedad de Danon","volume":"63","author":"Braksator","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.disamonth.2025.102015_bib0011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2019.01.020","article-title":"Danon disease: gender differences in presentation and outcomes","volume":"286","author":"Brambatti","year":"2019","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0012","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1399-3046.2007.00874.x","article-title":"Danon disease with typical early-onset cardiomyopathy in a male: focus on a novel LAMP-2 mutation","volume":"12","author":"Bui","year":"2008","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0013","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pediatrneurol.2008.03.011","article-title":"Danon disease: an unusual presentation of autism","volume":"39","author":"Burusnukul","year":"2008","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0014","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/nan.12587","article-title":"Review: Danon disease: review of natural history and recent advances","volume":"46","author":"Cenacchi","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"10.1016\/j.disamonth.2025.102015_bib0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/hrt.2003.029504","article-title":"Dano\u2019s disease as a cause of hypertrophic cardiomyopathy: A systematic survey","volume":"90","author":"Charron","year":"2004","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1083\/jcb.101.1.85","article-title":"Identification of two lysosomal membrane glycoproteins","volume":"101","author":"Chen","year":"1985","journal-title":"J Cell Biol"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102015_bib0017","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/eurheartj\/ehr420","article-title":"Danon disease as a cause of concentric left ventricular hypertrophy in patients who underwent endomyocardial biopsy","volume":"33","author":"Cheng","year":"2012","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0018","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jacc.2011.04.051","article-title":"Wolff-Parkinson-White syndrome and concentric left ventricular hypertrophy in a teenager: Danon disease","volume":"59","author":"Cheng","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102015_bib0019","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/jhg.2012.72","article-title":"Danon disease: focusing on heart","volume":"57","author":"Cheng","year":"2012","journal-title":"J Hum Genet"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1073\/pnas.1808618116","article-title":"LAMP-2B regulates human cardiomyocyte function by mediating autophagosome\u2013lysosome fusion","volume":"116","author":"Chi","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neurol.2018.04.012","article-title":"Abundant electrical myotonia and left ventricular noncompaction: unusual features of Danon disease due to a novel mutation in LAMP2 gene","volume":"175","author":"Codron","year":"2019","journal-title":"Rev Neurol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0022","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10545-010-9251-y","article-title":"Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation","volume":"34","author":"Cottinet","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102015_bib0023","first-page":"1355.e23","article-title":"Identification of two novel LAMP2 gene mutations in Danon disease","volume":"32","author":"Cs\u00e1nyi","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.disamonth.2025.102015_bib0024","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fcell.2020.00031","article-title":"The lysosomal membrane protein Lamp2 alleviates lysosomal cell death by promoting autophagic flux in ischemic cardiomyocytes","volume":"8","author":"Cui","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102015_bib0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.114.001105","article-title":"Danon disease: clinical features, evaluation, and management","volume":"7","author":"D\u2019souza","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0026","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/20009666.2017.1324239","article-title":"Danon disease for the cardiologist: case report and review of the literature","volume":"7","author":"D\u2019souza","year":"2017","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.31.1.51","article-title":"Lysosomal glycogen storage disease with normal acid maltase","volume":"31","author":"Danon","year":"1981","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0028","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1017\/S1047951111000564","article-title":"Danon disease: characteristic late gadolinium enhancement pattern on cardiac magnetic resonance imaging","volume":"21","author":"Dara","year":"2011","journal-title":"Cardiol Young"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102015_bib0029","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.nmd.2008.09.008","article-title":"Danon disease: a novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression","volume":"18","author":"Di Blasi","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2019.04.002","article-title":"Heart transplantation in Danon disease: long term single centre experience and review of the literature","volume":"63","author":"Di Nora","year":"2020","journal-title":"Eur J Med Genet"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0031","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1253\/circj.CJ-08-0241","article-title":"Novel LAMP-2 mutation in a family with danon disease presenting with hypertrophic cardiomyopathy","volume":"73","author":"Dougu","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.disamonth.2025.102015_bib0032","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2019.06.013","article-title":"Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy","volume":"133","author":"Dvornikov","year":"2019","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0033","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0960-8966(94)90025-6","article-title":"Lysosomal glycogen storage with normal acid maltase: a familial study with successful heart transplant","volume":"4","author":"Dworzak","year":"1994","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0034","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mus.20471","article-title":"Novel LAMP-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease","volume":"33","author":"Echaniz-Laguna","year":"2006","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00401-015-1385-4","article-title":"Danon disease: a phenotypic expression of LAMP-2 deficiency","volume":"129","author":"Endo","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"S1","key":"10.1016\/j.disamonth.2025.102015_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.04594","article-title":"The absence of Lamp2 triggers autophagy and mitochondrial biogenesis in skeletal muscle","volume":"34","author":"Erlich","year":"2020","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/auto.1.1.1270","article-title":"Maturation of autophagic vacuoles in Mammalian cells","volume":"1","author":"Eskelinen","year":"2005","journal-title":"Autophagy"},{"issue":"5\u20136","key":"10.1016\/j.disamonth.2025.102015_bib0038","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2006.08.005","article-title":"Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy","volume":"27","author":"Eskelinen","year":"2006","journal-title":"Mol Asp Med"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102015_bib0039","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1600-0854.2005.00337.x","article-title":"Unifying nomenclature for the isoforms of the lysosomal membrane protein LAMP-2","volume":"6","author":"Eskelinen","year":"2005","journal-title":"Traffic"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","article-title":"At the acidic edge: emerging functions for lysosomal membrane proteins","volume":"13","author":"Eskelinen","year":"2003","journal-title":"Trends Cell Biol"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0041","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2353\/ajpath.2006.050646","article-title":"Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in danon disease","volume":"168","author":"Fanin","year":"2006","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.disamonth.2025.102015_bib0042","first-page":"1","article-title":"Danon disease-associated lamp-2 deficiency drives metabolic signature indicative of mitochondrial aging and fibrosis in cardiac tissue and hipsc-derived cardiomyocytes","volume":"9","author":"Favero","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0043","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.3390\/ijms24043739","article-title":"Mitochondria-targeted antioxidants, an innovative class of antioxidant compounds for neurodegenerative diseases: perspectives and limitations","volume":"24","author":"Fields","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0044","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/ehf2.14417","article-title":"Identification of a novel splicing-altering LAMP2 variant in a Chinese family with Danon disease","volume":"10","author":"Fu","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0045","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.amjcard.2016.06.037","article-title":"Identification of LAMP2 mutations in early-onset Danon disease with hypertrophic cardiomyopathy by targeted next-generation sequencing","volume":"118","author":"Fu","year":"2016","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0046","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4161\/auto.23002","article-title":"Discovery of a novel type of autophagy targeting RNA","volume":"9","author":"Fujiwara","year":"2013","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.disamonth.2025.102015_bib0047","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4161\/auto.24880","article-title":"Direct uptake and degradation of DNA by lysosomes","volume":"9","author":"Fujiwara","year":"2013","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0048","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/1120672119832183","article-title":"Retinal dystrophy associated with Danon disease and pathogenic mechanism through LAMP2-mutated retinal pigment epithelium","volume":"30","author":"Fukushima","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0049","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/abbi.1999.1147","article-title":"Differential expression of the lysosome-associated membrane proteins in normal human tissues","volume":"365","author":"Furuta","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.disamonth.2025.102015_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131189","article-title":"Clinical features of pediatric Danon disease and the importance of early diagnosis","volume":"389","author":"Gandaeva","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.disamonth.2025.102015_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2021.06.020","article-title":"Synthetic modified messenger RNA for therapeutic applications","volume":"131","author":"Gao","year":"2021","journal-title":"Acta Biomater"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0052","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejmg.2018.05.015","article-title":"A new phenotype of severe dilated cardiomyopathy associated with a mutation in the LAMP2 gene previously known to cause hypertrophic cardiomyopathy in the context of Danon disease","volume":"62","author":"Gourzi","year":"2019","journal-title":"Eur J Med Genet"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102015_bib0053","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJMoa2412392","article-title":"Phase 1 study of AAV9.LAMP2B gene therapy in Danon disease","volume":"392","author":"Greenberg","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0054","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0002-9610(71)90316-3","article-title":"Determinants of operative risk in human heart transplantation","volume":"122","author":"Griepp","year":"1971","journal-title":"Am J Surg"},{"issue":"22","key":"10.1016\/j.disamonth.2025.102015_bib0055","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.4103\/0366-6999.245156","article-title":"Cardiac resynchronization therapy-pacemaker implantation guided by three-dimensional electroanatomic mapping for a Chinese young man with Danon disease","volume":"131","author":"Guo","year":"2018","journal-title":"Chin Med J"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0056","first-page":"1527","article-title":"Danon disease: two patients with atrial fibrillation in a single family and review of the literature","volume":"18","author":"Guo","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.disamonth.2025.102015_bib0057","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yjmcc.2017.05.007","article-title":"Impaired mitophagy facilitates mitochondrial damage in Danon disease","volume":"108","author":"Hashem","year":"2017","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102015_bib0058","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/stem.2015","article-title":"Brief report: oxidative stress mediates cardiomyocyte apoptosis in a human model of danon disease and heart failure","volume":"33","author":"Hashem","year":"2015","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0059","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jjcc.2014.09.011","article-title":"Early diagnosis of Danon disease: flow cytometric detection of lysosome-associated membrane protein-2-negative leukocytes","volume":"66","author":"Hashida","year":"2015","journal-title":"J Cardiol"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5414\/NP300465","article-title":"Danon disease caused by two novel mutations of the LAMP2 gene: implications for two ends of the clinical spectrum","volume":"31","author":"Hong","year":"2012","journal-title":"Clin Neuropathol"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102015_bib0061","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2003-43262","article-title":"Identification of a novel LAMP2 mutation responsible for X-chromosomal dominant Danon disease","volume":"34","author":"Horv\u00e1th","year":"2003","journal-title":"Neuropediatrics"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102015_bib0062","first-page":"557","article-title":"Heart transplantation: an In-depth survival analysis","volume":"8","author":"Hsich","year":"2020","journal-title":"JACC: Heart Fail"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102015_bib0063","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/jce.14049","article-title":"Arrhythmias and fasciculoventricular pathways in patients with Danon disease: a single center experience","volume":"30","author":"Jhaveri","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0064","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7150\/ijbs.10174","article-title":"Coenzyme Q10 protects astrocytes from ROS-induced damage through inhibition of Mitochondria-mediated cell death pathway","volume":"11","author":"Jing","year":"2015","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(91)90109-K","article-title":"Cardiomyopathy, mental retardation, and autophagic vacuolar myopathy. Abnormal MRI findings in the head","volume":"105","author":"Kashio","year":"1991","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"10.1016\/j.disamonth.2025.102015_bib0066","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0022-510X(96)00077-9","article-title":"Cerebral oxygen and glucose metabolism in glycogen stroage disease with normal acid maltase: case report","volume":"140","author":"Katsumi","year":"1996","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102015_bib0067","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1091\/mbc.e07-11-1155","article-title":"Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy","volume":"19","author":"Kaushik","year":"2008","journal-title":"Mol Biol Cell"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102015_bib0068","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070674","article-title":"A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy","volume":"8","author":"Khandia","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0069","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/mus.21614","article-title":"A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease","volume":"41","author":"Kim","year":"2010","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.14503\/THIJ-13-3279","article-title":"Asymptomatic young man with Danon disease","volume":"41","author":"Kim","year":"2014","journal-title":"Tex Heart Inst J"},{"issue":"19","key":"10.1016\/j.disamonth.2025.102015_bib0071","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108863","article-title":"Autophagy in major human diseases","volume":"40","author":"Klionsky","year":"2021","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.1994.2620","article-title":"Complete cDNA sequence of human lysosome-associated membrane protein-2","volume":"205","author":"Konecki","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0073","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1006\/bbrc.1995.2528","article-title":"An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner","volume":"215","author":"Konecki","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102015_bib0074","first-page":"1204","article-title":"Cardiac arrhythmias in patients with Danon disease","volume":"19","author":"Konrad","year":"2017","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/aos.14478","article-title":"Pigmentary retinopathy can indicate the presence of pathogenic LAMP2 variants even in somatic mosaic carriers with no additional signs of Danon disease","volume":"99","author":"Kousal","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0076","first-page":"e2155","article-title":"A mild version of Danon disease caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene","volume":"10","author":"Kyaw","year":"2018","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102015_bib0077","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0960-8966(02)00179-7","article-title":"Danon\u2019s disease (X-linked vacuolar cardiomyopathy and myopathy): a case with a novel Lamp-2 gene mutation","volume":"12","author":"Lacoste-Collin","year":"2002","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"10.1016\/j.disamonth.2025.102015_bib0078","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1212\/01.WNL.0000141858.80738.AA","article-title":"Charcot-Marie-tooth features and maculopathy in a patient with Danon disease","volume":"63","author":"Lafor\u00eat","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2025.102015_bib0079","unstructured":"Law, C. (2015). Generation of neurons from LAMP2-deficient iPSCs for modeling lysosomal dysfunction induced neuropathogenesis. https:\/\/api.semanticscholar.org\/CorpusID:147572558"},{"key":"10.1016\/j.disamonth.2025.102015_bib0080","first-page":"335","article-title":"Lysosomal membrane permeabilization is involved in oxidative stress-induced apoptotic cell death in LAMP2-deficient iPSCs-derived cerebral cortical neurons","volume":"5","author":"Law","year":"2016","journal-title":"Biochem Biophys Rep"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0081","doi-asserted-by":"crossref","first-page":"227","DOI":"10.14797\/mdcj-12-4-227","article-title":"Hypertrophic cardiomyopathy with unusual extensive scarring pattern: Danon disease","volume":"12","author":"Le","year":"2016","journal-title":"Methodist DeBakey Cardiovasc J"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0082","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2019.10.138","article-title":"Lysosome-associated membrane protein-2 deficiency increases the risk of reactive oxygen species-induced ferroptosis in retinal pigment epithelial cells","volume":"521","author":"Lee","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0083","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1083\/jcb.100.6.1839","article-title":"Glycoproteins of the lysosomal membrane","volume":"100","author":"Lewis","year":"1985","journal-title":"J Cell Biol"},{"issue":"September2016","key":"10.1016\/j.disamonth.2025.102015_bib0084","article-title":"Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export","volume":"5","author":"Li","year":"2016","journal-title":"ELife"},{"key":"10.1016\/j.disamonth.2025.102015_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.763240","article-title":"Case report: a novel LAMP2 splice-altering mutation causes cardiac-only Danon disease","volume":"8","author":"Li","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.disamonth.2025.102015_bib0086","first-page":"11","article-title":"Danon disease due to a novel LAMP2 microduplication","volume":"14","author":"Lines","year":"2014","journal-title":"JIMD Rep"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102015_bib0087","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1083\/jcb.102.5.1593","article-title":"Lysosomal membrane dynamics: structure and interorganellar movement of a major lysosomal membrane glycoprotein","volume":"102","author":"Lippincott-Schwartz","year":"1986","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0088","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47030176","article-title":"The application and molecular mechanisms of mitochondria-targeted antioxidants in chemotherapy-induced cardiac injury","volume":"47","author":"Liu","year":"2025","journal-title":"Curr Issues Mol Biol"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102015_bib0089","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1002\/mgg3.638","article-title":"Prevalence and clinical characteristics of Danon disease among patients with left ventricular hypertrophy and concomitant electrocardiographic preexcitation","volume":"7","author":"Liu","year":"2019","journal-title":"Mol Genet Genom Med"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102015_bib0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006704","article-title":"Fasciculoventricular pathways responsible for ventricular preexcitation in patients with Danon Disease","volume":"11","author":"Liu","year":"2018","journal-title":"Circ Arrhythmia electrophysiol"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0091","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nmd.2004.12.007","article-title":"Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease)","volume":"15","author":"Lobrinus","year":"2005","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0092","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.recesp.2018.04.027","article-title":"Clinical findings and prognosis of Danon disease. An analysis of the Spanish multicenter Danon registry","volume":"72","author":"L\u00f3pez-Sainz","year":"2019","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0093","first-page":"284","article-title":"Novel LAMP2 mutations in Chinese patients with Danon disease cause varying degrees of clinical severity","volume":"33","author":"Luo","year":"2014","journal-title":"Clin Neuropathol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0094","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1038\/s41598-018-24351-w","article-title":"Characterisation of Lamp2-deficient rats for potential new animal model of Danon disease","volume":"8","author":"Ma","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10545-013-9617-z","article-title":"Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics","volume":"37","author":"Majer","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.disamonth.2025.102015_bib0096","article-title":"Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease","volume":"12","author":"Manso","year":"2020"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102015_bib0097","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.nmd.2016.09.025","article-title":"Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease","volume":"26","author":"Marino","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102015_bib0098","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0099","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1540-8159.2007.00937.x","article-title":"Pacemaker malfunctions in Danon\u2019s disease","volume":"31","author":"Marras","year":"2008","journal-title":"PACE - Pacing Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43042-022-00250-8","article-title":"Myocardiocyte autophagy in the context of myocardiocytes regeneration: a potential novel therapeutic strategy","volume":"23","author":"Marzoog","year":"2022","journal-title":"Egypt J Med Hum Genet"},{"issue":"15","key":"10.1016\/j.disamonth.2025.102015_bib0101","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1073\/pnas.0507436103","article-title":"Consequences of the selective blockage of chaperone-mediated autophagy","volume":"103","author":"Massey","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102015_bib0102","first-page":"717","article-title":"Hepatic involvement in a case of lysosomal glycogen storage disease with normal acid maltase","volume":"39","author":"Matsumoto","year":"1999","journal-title":"Clin Neurol"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102015_bib0103","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1096\/fj.14-269092","article-title":"Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates","volume":"29","author":"Mattar","year":"2015","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0104","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/13816810.2019.1627464","article-title":"Danon disease presenting with early onset of hypertrophic cardiomyopathy and peripheral pigmentary retinal dystrophy in a female with a de novo novel mosaic mutation in the LAMP2 gene","volume":"40","author":"Meinert","year":"2019","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0105","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s12192-019-01039-2","article-title":"Coenzyme Q10 supplementation acts as antioxidant on dystrophic muscle cells","volume":"24","author":"Mizobuti","year":"2019","journal-title":"Cell Stress Chaperones"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0106","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-510X(98)00242-1","article-title":"Lysosomal glycogen storage disease with normal acid maltase with early fatal outcome","volume":"160","author":"Morisawa","year":"1998","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0107","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nmd.2005.02.008","article-title":"Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene","volume":"15","author":"Musumeci","year":"2005","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0108","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/mus.20930","article-title":"Danon disease due to a novel splice mutation in the LAMP2 gene","volume":"37","author":"Nadeau","year":"2008","journal-title":"Muscle Nerve"},{"issue":"18","key":"10.1016\/j.disamonth.2025.102015_bib0109","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCULATIONAHA.115.019847","article-title":"Amelioration of X-linked related autophagy failure in Danon disease with DNA methylation inhibitor","volume":"134","author":"Ng","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0110","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1038\/s41598-018-21602-8","article-title":"Small-vessel vasculopathy due to aberrant autophagy in LAMP-2 deficiency","volume":"8","author":"Nguyen","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0111","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.spen.2006.06.004","article-title":"Autophagic vacuolar myopathy","volume":"13","author":"Nishino","year":"2006","journal-title":"Semin Pediatr Neurol"},{"issue":"6798","key":"10.1016\/j.disamonth.2025.102015_bib0112","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacoular cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0113","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13335","article-title":"Heart transplantation in two adolescents with Danon disease","volume":"23","author":"Oren","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"26","key":"10.1016\/j.disamonth.2025.102015_bib0114","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.2174\/092986711796957257","article-title":"Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues","volume":"18","author":"Orsucci","year":"2011","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1532-429X-11-12","article-title":"Cardiovascular magnetic resonance findings in a case of Danon disease","volume":"11","author":"Piotrowska-Kownacka","year":"2009","journal-title":"J Cardiovasc Magn Reson"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102015_bib0116","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102314","article-title":"Multifaceted impact of SGLT2 inhibitors in heart failure patients: exploring diverse mechanisms of action","volume":"12","author":"Piperis","year":"2024","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0117","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ophtha.2006.02.030","article-title":"Ophthalmic manifestations of Danon disease","volume":"113","author":"Prall","year":"2006","journal-title":"Ophthalmology"},{"issue":"SUPPL. 1","key":"10.1016\/j.disamonth.2025.102015_bib0118","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/s10545-009-1097-9","article-title":"Danon disease: case report and detection of new mutation","volume":"32","author":"Regelsberger","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.disamonth.2025.102015_bib0119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2018.01.012","article-title":"MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload","volume":"117","author":"Ribeiro","year":"2018","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0120","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ymgme.2017.06.008","article-title":"Heterogeneity in a large pedigree with Danon disease: implications for pathogenesis and management","volume":"123","author":"Roos","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.disamonth.2025.102015_bib0121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40478-014-0182-y","article-title":"LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease","volume":"3","author":"Rothaug","year":"2015","journal-title":"Acta Neuropathol Commun"},{"issue":"51","key":"10.1016\/j.disamonth.2025.102015_bib0122","doi-asserted-by":"crossref","first-page":"35111","DOI":"10.1074\/jbc.M114.609446","article-title":"Structure of transmembrane domain of lysosome-associated membrane protein type 2a (LAMP-2A) reveals key features for substrate specificity in chaperone-mediated autophagy","volume":"289","author":"Rout","year":"2014","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.disamonth.2025.102015_bib0123","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.amjcard.2017.12.044","article-title":"Impact of advanced therapies for improving survival to heart transplant in patients with hypertrophic cardiomyopathy","volume":"121","author":"Rowin","year":"2018","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0124","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mus.21252","article-title":"Danon disease: further clinical and molecular heterogeneity","volume":"39","author":"Sabourdy","year":"2009","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1471-4914(00)01868-2","article-title":"Disease model: LAMP-2 enlightens Danon disease","volume":"7","author":"Saftig","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.disamonth.2025.102015_bib0126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2017.06.031","article-title":"Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy)","volume":"245","author":"Samad","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.disamonth.2025.102015_bib0127","first-page":"1","article-title":"Overlapping functions between Lamp2a and Lamp2b in cardiac autophagy","author":"Sampaio Cruz","year":"2025","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s11658-025-00691-0","article-title":"VEXAS, Chediak-Higashi syndrome and Danon disease: myeloid cell endo-lysosomal pathway dysfunction as a common denominator?","volume":"30","author":"Savy","year":"2025","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0129","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1582-4934.2009.00973.x","article-title":"Role for LAMP-2 in endosomal cholesterol transport","volume":"15","author":"Schneede","year":"2011","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archopht.125.2.231","article-title":"Retinopathy in Danon disease","volume":"125","author":"Schorderet","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102015_bib0131","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/tra.12056","article-title":"Lysosomal membrane proteins and their central role in physiology","volume":"14","author":"Schwake","year":"2013","journal-title":"Traffic"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0132","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mtor signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102015_bib0133","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11897-019-00432-3","article-title":"Updates on heart transplantation","volume":"16","author":"Shah","year":"2019","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0134","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/mus.21811","article-title":"Functional performance and muscle strength phenotypes in men and women with Danon disease","volume":"42","author":"Stevens-Lapsley","year":"2010","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00395-006-0591-6","article-title":"LAMP-2 deficient mice show depressed cardiac contractile function without significant changes in calcium handling","volume":"101","author":"Stypmann","year":"2006","journal-title":"Basic Res Cardiol"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102015_bib0136","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/jn\/nxac079","article-title":"Coenzyme Q10as adjunctive therapy for cardiovascular disease and hypertension: a systematic review","volume":"152","author":"Sue-Ling","year":"2022","journal-title":"J Nutr"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102015_bib0137","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.58.12.1773","article-title":"Clinicopathological features of genetically confirmed Danon disease","volume":"58","author":"Sugie","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102015_bib0138","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113507","article-title":"A nationwide survey on danon disease in Japan","volume":"19","author":"Sugie","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102015_bib0139","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0960-8966(03)00105-6","article-title":"Characterization of Danon disease in a male patient and his affected mother","volume":"13","author":"Sugie","year":"2003","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102015_bib0140","doi-asserted-by":"crossref","DOI":"10.3390\/biom14101272","article-title":"History and perspective of LAMP-2 deficiency (Danon Disease)","volume":"14","author":"Sugie","year":"2024","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0141","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/15548627.2017.1280219","article-title":"MitoQ regulates autophagy by inducing a pseudo-mitochondrial membrane potential","volume":"13","author":"Sun","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.disamonth.2025.102015_bib0142","first-page":"767","article-title":"A case study and literature review of the diagnosis of Danon disease in patients presenting only with severe cardiac symptoms","volume":"16","author":"Sun","year":"2023","journal-title":"Pharmacogenomics Pers Med"},{"issue":"17","key":"10.1016\/j.disamonth.2025.102015_bib0143","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1161\/CIR.0b013e3181de7097","article-title":"Utility of real-time 3-dimensional echocardiography and magnetic resonance imaging for evaluation of danon disease","volume":"121","author":"Tada","year":"2010","journal-title":"Circulation"},{"issue":"6798","key":"10.1016\/j.disamonth.2025.102015_bib0144","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/35022595","article-title":"Accumulation of autophagic vacuoles and cardiomyopathy LAMP-2-deficient mice","volume":"406","author":"Tanaka","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102015_bib0145","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1017\/S1047951114002303","article-title":"Treatment of depression in an adolescent with cardiomyopathy and arrhythmia","volume":"25","author":"Tanidir","year":"2014","journal-title":"Cardiol Young"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102015_bib0146","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10038-007-0184-8","article-title":"Danon disease presenting with dilated cardiomyopathy and a complex phenotype","volume":"52","author":"Taylor","year":"2007","journal-title":"J Hum Genet"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0147","doi-asserted-by":"crossref","first-page":"69","DOI":"10.31083\/j.rcm.2018.02.903","article-title":"Repeat cardiac transplant indicated by severe cardiac allograft vasculopathy in a patient with Danon disease","volume":"19","author":"Thakur","year":"2018","journal-title":"Rev Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102015_bib0148","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00417-011-1857-8","article-title":"Cone-rod dystrophy can be a manifestation of Danon disease","volume":"250","author":"Thiadens","year":"2012","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0149","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/IAE.0000000000000736","article-title":"The physiology of the retinal pigment epithelium in Danon disease","volume":"36","author":"Thompson","year":"2016","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0150","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacc.2009.11.019","article-title":"Distinct clinical and histopathological presentations of Danon cardiomyopathy in young women","volume":"55","author":"Toib","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0151","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nmd.2007.09.008","article-title":"Danon disease: a novel Lamp-2 gene mutation in a family with four affected members","volume":"18","author":"Tu\u00f1\u00f3n","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0152","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0022-510X(94)90135-X","article-title":"Morphologic findings in biopsied skeletal muscle and cultured fibroblasts from a female patient with Danon\u2019s disease (lysosomal glycogen storage disease without acid maltase deficiency)","volume":"127","author":"Usuki","year":"1994","journal-title":"J Neurol Sci"},{"issue":"21","key":"10.1016\/j.disamonth.2025.102015_bib0153","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/eurheartj\/ehv332","article-title":"Danon disease: a rare cause of left ventricular hypertrophy with cardiac magnetic resonance follow-up","volume":"37","author":"Vago","year":"2016","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.disamonth.2025.102015_bib0154","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/01.wnl.0000309219.61785.b3","article-title":"Extension of the clinical spectrum of Danon disease","volume":"70","author":"Van Der Kooi","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mus.23517","article-title":"Late profound muscle weakness following heart transplantation due to danon disease","volume":"47","author":"Van Der Starre","year":"2013","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0156","first-page":"129","article-title":"LAMP2 Microdeletions in patients with Danon disease","volume":"3","author":"Vatta","year":"2010","journal-title":"Circ: Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0157","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12016-017-8598-3","article-title":"A critical evaluation of liver pathology in humans with Danon disease and experimental correlates in a rat model of LAMP-2 deficiency","volume":"53","author":"Wang","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0158","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1741-7007-10-62","article-title":"Crystal structure of the conserved domain of the DC lysosomal associated membrane protein: implications for the lysosomal glycocalyx","volume":"10","author":"Wilke","year":"2012","journal-title":"BMC Biol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0159","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.66.2.2","article-title":"Lamp2 Deficiency enhances susceptibility to oxidative stress-induced RPE degeneration","volume":"66","author":"Wu","year":"2025","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13000-021-01100-8","article-title":"Danon disease: a case report and literature review","volume":"16","author":"Xu","year":"2021","journal-title":"Diagn Pathol"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0161","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202102001","article-title":"Lysosome biogenesis: regulation and functions","volume":"220","author":"Yang","year":"2021","journal-title":"J Cell Biol"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102015_bib0162","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.105.546481","article-title":"Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children","volume":"112","author":"Yang","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102015_bib0163","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1747-0803.2007.00132.x","article-title":"Danon disease as a cause of autophagic vacuolar myopathy","volume":"2","author":"Yang","year":"2007","journal-title":"Congenit Heart Dis"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102015_bib0164","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/ajmg.a.38320","article-title":"Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation)","volume":"173","author":"Yardeni","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.disamonth.2025.102015_bib0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yjmcc.2017.11.019","article-title":"Characteristics of induced pluripotent stem cells from clinically divergent female monozygotic twins with Danon disease","volume":"114","author":"Yoshida","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"34","key":"10.1016\/j.disamonth.2025.102015_bib0166","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/eurheartj\/ehx722","article-title":"A rare phenotype of heterozygous danon disease mimicking apical hypertrophic cardiomyopathy","volume":"39","author":"Yu","year":"2018","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102015_bib0167","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/jce.12142","article-title":"Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy","volume":"24","author":"Zaki","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102015_bib0168","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tcm.2021.10.012","article-title":"Clinical features of Danon disease and insights gained from LAMP-2 deficiency models","volume":"33","author":"Zhai","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"14","key":"10.1016\/j.disamonth.2025.102015_bib0169","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.molcel.2023.06.004","article-title":"Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel","volume":"83","author":"Zhang","year":"2023","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102015_bib0170","first-page":"89","article-title":"Clinical and genetic profile of Chinese children with Danon disease: a single-center retrospective cohort study","volume":"41","author":"Zhang","year":"2024","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102015_bib0171","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1002\/mgg3.561","article-title":"A family with Danon disease caused by a splice site mutation in LAMP2 that generates a truncated protein","volume":"7","author":"Zhou","year":"2019","journal-title":"Mol Genet Genom Med"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102015_bib0172","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ajhg.2019.02.003","article-title":"Systemic mRNA therapy for the treatment of Fabry disease: preclinical studies in wild-type mice, Fabry Mouse model, and wild-type non-human primates","volume":"104","author":"Zhu","year":"2019","journal-title":"Am J Hum Genet"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502925001695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502925001695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:38:33Z","timestamp":1764945513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502925001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":172,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0011502925001695"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2025.102015","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danon disease: From genetic origins and molecular defects to therapeutic advances","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2025.102015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102015"}}